Clinical Trials on Breast Milk in South Africa
Total 907 results
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupActive, not recruitingBreast CancerUnited States, Australia, Switzerland, Italy, Canada, Belgium, Peru, United Kingdom, Egypt, New Zealand, Slovenia, South Africa, Sweden, Hungary, India, Germany, Brazil
-
Hoffmann-La RocheCompletedBreast CancerSweden, Canada, South Africa, Spain, United Kingdom, Germany, Taiwan, Switzerland, New Zealand, Italy, Bosnia and Herzegovina, Serbia, Portugal, Greece, Romania, Brazil, Korea, Republic of, Mexico, Croatia, Bahamas
-
Eli Lilly and CompanyCompleted
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States, Argentina, Australia, Brazil, Korea, Republic of, Mexico, Puerto Rico, Taiwan
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); American College of Radiology Imaging NetworkActive, not recruitingStage II Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedBreast Cancer | Hot FlashesUnited States
-
ETOP IBCSG Partners FoundationNSABP Foundation IncCompletedBreast CancerSpain, United States, Australia, Belgium, Switzerland, Canada, Peru, Netherlands, Hungary, South Africa
-
PfizerCompletedBreast CancerKorea, Republic of
-
Pharmatech OncologyUnknownBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | Menopausal SymptomsUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
OncotechUnknown
-
International Agency for Research on CancerBarretos Cancer Hospital; Instituto Nacional de Salud Publica, Mexico; University... and other collaboratorsRecruitingBreast Cancer FemaleChile, Colombia, Brazil, Costa Rica, Mexico
-
Royal North Shore HospitalRecruitingBreast Cancer | Post MastectomyAustralia
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Australia, Bosnia and Herzegovina
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
National Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
Provista Diagnostics, IncUnknownBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerChina, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
SCRI Development Innovations, LLCEisai Inc.CompletedHER2 Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom, Spain, Australia, Sweden
-
Genentech, Inc.CompletedBreast CancerUnited States, Spain, Belgium, Australia, United Kingdom
-
R-PharmCompletedBreast Cancer | MetastasesUnited States, Netherlands, Argentina, Canada, South Africa, Mexico, Norway, Sweden, France, Germany
-
Dana-Farber Cancer InstituteGateway for Cancer Research; Susan G. Komen Breast Cancer FoundationActive, not recruiting
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
Genentech, Inc.TerminatedBreast CancerUnited States, Spain, United Kingdom, Germany, Korea, Republic of, Australia
-
Immutep S.A.S.RecruitingBreast CarcinomaSpain, United States, Belgium
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Genentech, Inc.No longer availableMetastatic Breast CancerUnited States
-
Eli Lilly and CompanyGenentech, Inc.CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
Myelo Therapeutics GmbHCompletedBreast Cancer | Myelosuppression | Chemotherapy-Induced NeutropeniaGermany
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina